The Uromigos

401 Avsnitt

1. Episode 343: ESMO 2024 - TiNivo-2 Trial

   Publicerades: 2024-09-14
2. Episode 342: ESMO 2024 Preview with Silke Gillessen

   Publicerades: 2024-09-03
3. Episode 341: Hormone Resistance in Prostate Cancer

   Publicerades: 2024-08-27
4. Episode 340: Cancer Immunity Cycle Update

   Publicerades: 2024-08-19
5. Episode 339: Tres Uramigas analizan lineamientos de ESMO para GU

   Publicerades: 2024-08-09
6. Episode 338: RCC: Debulking Nephrectomy, Adjuvant Therapy Future and More

   Publicerades: 2024-08-06
7. Episode 337: Updated NCCN Guidelines in RCC

   Publicerades: 2024-07-30
8. Episode 336: Which patients are not suitable for 1st line EVP in bladder cancer

   Publicerades: 2024-07-24
9. Episode 335: Novel immune therapies for renal cancer

   Publicerades: 2024-07-19
10. Episodio 334 en español: Tres Uramigas ASCO 2024

    Publicerades: 2024-07-11
11. Episode 333: The Uromigos Cup - The Netherlands

    Publicerades: 2024-07-05
12. Episode 332: The Uromigos Cup - Germany's Entry

    Publicerades: 2024-06-26
13. Episode 331: AUA 2024 NMIBC Highlights

    Publicerades: 2024-06-21
14. Episode 330: ASCO 2024 Highlights

    Publicerades: 2024-06-10
15. Episode 329: Japan in the Uromigos Cup qualifying round

    Publicerades: 2024-06-07
16. Episode 328 ASCO24: Emergency podcast - what the NADINA trial means for preoperative GU cancer studies

    Publicerades: 2024-06-05
17. Episode 327 ASCO24: CM901 and EV302 Efficacy and QOL Updates

    Publicerades: 2024-06-04
18. Episode 326 ASCO24: KIM-1 in Renal Cancer

    Publicerades: 2024-06-03
19. Episode 325 ASCO24: KN426 and the CLEAR trial - tissue based biomarkers for kidney cancer

    Publicerades: 2024-06-03
20. Episode 324 ASCO24: SURE1 neoadjuvant sacituzumab govitecan in UC

    Publicerades: 2024-06-02